Cargando…
Recent Progress in Bioconjugation Strategies for Liposome-Mediated Drug Delivery
In nanoparticle (NP)-mediated drug delivery, liposomes are the most widely used drug carrier, and the only NP system currently approved by the FDA for clinical use, owing to their advantageous physicochemical properties and excellent biocompatibility. Recent advances in liposome technology have been...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730700/ https://www.ncbi.nlm.nih.gov/pubmed/33271886 http://dx.doi.org/10.3390/molecules25235672 |